Translational spinal cord injury research: Preclinical guidelines and challenges

Handbook of Clinical Neurology

Volumn 109, Issue , 2012, Pages 411-433

  Reier, Paul J ^a   Lane, Michael A ^a   Hall, Edward D ^d   Teng, Y D ^c   Howland, Dena R ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867829909     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52137-8.00026-7     Document Type: Chapter

References (260)

1. Akhtar A.Z., Pippin J.J., Sandusky C.B. Animal models in spinal cord injury: a review. Rev Neurosci 2008, 19:47-60.
2. Akhtar A.Z., Pippin J.J., Sandusky C.B. Animal studies in spinal cord injury: a systematic review of methylprednisolone. Altern Lab Anim 2009, 37:43-62.
3. Anderson K.D. Targeting recovery: priorities of the spinal cord-injured population. J Neurotrauma 2004, 21:1371-1383.
4. Anderson D.K., Saunders R.D., Demediuk P., et al. Lipid hydrolysis and peroxidation in injured spinal cord: partial protection with methylprednisolone or vitamin E and selenium. Cent Nerv Syst Trauma 1985, 2:257-267.
5. Anderson D.K., Howland D.R., Reier P.J. Fetal neural grafts and repair of the injured spinal cord. Brain Pathol 1995, 5:451-457.
6. Anderson D.K., Beattie M., Blesch A., et al. Recommended guidelines for studies of human subjects with spinal cord injury. Spinal Cord 2005, 43:453-458.
7. Anderson K.D., Gunawan A., Steward O. Spinal pathways involved in the control of forelimb motor function in rats. Exp Neurol 2007, 206:318-331.
8. Anderson K.D., Sharp K.G., Steward O. Bilateral cervical contusion spinal cord injury in rats. Exp Neurol 2009, 220:9-22.
9. Bamford J.A., Mushahwar V.K. Intraspinal microstimulation for the recovery of function following spinal cord injury. Prog Brain Res 2011, 194:227-239.
10. Bareyre F.M., Kerschensteiner M., Raineteau O., et al. The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat Neurosci 2004, 7:269-277.
11. Barker R.A., Widner H. Immune problems in central nervous system cell therapy. NeuroRx 2004, 1:472-481.
12. Basso D.M. Behavioral testing after spinal cord injury: congruities, complexities, and controversies. J Neurotrauma 2004, 21:395-404.
13. Basso D.M., Beattie M.S., Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995, 12:1-21.
14. Basso D.M., Beattie M.S., Bresnahan J.C. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 1996, 139:244-256.
15. Basso D.M., Fisher L.C., Anderson A.J., et al. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 2006, 23:635-659.
16. Behrman A.L., Lawless-Dixon A.R., Davis S.B., et al. Locomotor training progression and outcomes after incomplete spinal cord injury. Phys Ther 2005, 85:1356-1371.
17. Benatar M. Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol Dis 2007, 26:1-13.
18. Blesch A., Tuszynski M.H. Spinal cord injury: plasticity, regeneration and the challenge of translational drug development. Trends Neurosci 2008, 32:41-47.
19. Blight A.R. Delayed demyelination and macrophage invasion: a candidate for secondary cell damage in spinal cord injury. Cent Nerv Syst Trauma 1985, 2:299-315.
20. Blight A.R., Tuszynski M.H. Clinical trials in spinal cord injury. J Neurotrauma 2006, 23:586-593.
21. Bose B., Osterholm J.L., Kalia M. Ganglioside-induced regeneration and reestablishment of axonal continuity in spinal cord-transected rats. Neurosci Lett 1986, 63:165-169.
22. Bracken M.B. Why animal studies are often poor predictors of human reactions to exposure. J R Soc Med 2009, 102:120-122.
23. Bracken M.B. Why are so many epidemiology associations inflated or wrong? Does poorly conducted animal research suggest implausible hypotheses?. Ann Epidemiol 2009, 19:220-224.
24. Bracken M.B., Collins W.F., Freeman D.F., et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA 1984, 251:45-52.
25. Bracken M.B., Shepard M.J., Collins W.F., et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990, 322:1405-1411.
26. Bracken M.B., Shepard M.J., Holford T.R., et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial National Acute Spinal Cord Injury Study. JAMA 1997, 277:1597-1604.
27. Bradbury E.J., Carter L.M. Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury. Brain Res Bull 2010, 84:306-316.
28. Bradbury E.J., Moon L.D., Popat R.J., et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416:636-640.
29. Braeuninger S., Kleinschnitz C. Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems. Exp Transl Stroke Med 2009, 1:8.
30. Braughler J.M., Hall E.D. Lactate and pyruvate metabolism in injured cat spinal cord before and after a single large intravenous dose of methylprednisolone. J Neurosurg 1983, 59:256-261.
31. Braughler J.M., Hall E.D., Means E.D., et al. Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury. J Neurosurg 1987, 67:102-105.
32. Bregman B.S., Kunkel-Bagden E., Schnell L., et al. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 1995, 378:498-501.
33. Bresnahan J.C., King J.S., Martin G.F., et al. A neuroanatomical analysis of spinal cord injury in the rhesus monkey (Macaca mulatta). J Neurol Sci 1976, 28:521-542.
34. Bresnahan J.C., Beattie M.S., Stokes B.T., et al. Three-dimensional computer-assisted analysis of graded contusion lesions in the spinal cord of the rat. J Neurotrauma 1991, 8:91-101.
35. Brock J.H., Rosenzweig E.S., Blesch A., et al. Local and remote growth factor effects after primate spinal cord injury. J Neurosci 2010, 30:9728-9737.
36. Brosamle C., Huber A.B., Fiedler M., et al. Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment. J Neurosci 2000, 20:8061-8068.
37. Brownstone R.M., Wilson J.M. Strategies for delineating spinal locomotor rhythm-generating networks and the possible role of Hb9 interneurones in rhythmogenesis. Brain Res Brain Res Rev 2008, 57:64-76.
38. Bunge M.B. Novel combination strategies to repair the injured mammalian spinal cord. J Spinal Cord Med 2008, 31:262-269.
39. Bunge M.B., Pearse D.D. Transplantation strategies to promote repair of the injured spinal cord. J Rehabil Res Dev 2003, 40:55-62.
40. Bunge M.B., Pearse D.D. Response to the report, " A re-assessment of a combinatorial treatment involving Schwann cell transplants and elevation of cyclic AMP on recovery of motor function following thoracic spinal cord injury in rats" by Sharp et al. (this volume). Exp Neurol 2012, 233:645-648.
41. Bunge R.P., Puckett W.R., Becerra J.L., et al. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv Neurol 1993, 59:75-89.
42. Bunge M.B., Holets V.R., Bates M.L., et al. Characterization of photochemically induced spinal cord injury in the rat by light and electron microscopy. Exp Neurol 1994, 127:76-93.
43. Busch S.A., Silver J. The role of extracellular matrix in CNS regeneration. Curr Opin Neurobiol 2007, 17:120-127.
44. Caggiano A.O., Zimber M.P., Ganguly A., et al. Chondroitinase ABCI improves locomotion and bladder function following contusion injury of the rat spinal cord. J Neurotrauma 2005, 22:226-239.
45. Cameron T., Prado R., Watson B.D., et al. Photochemically induced cystic lesion in the rat spinal cord. I. Behavioral and morphological analysis. Exp Neurol 1990, 109:214-223.
46. Cao Q., He Q., Wang Y., et al. Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury. J Neurosci 2010, 30:2989-3001.
47. Carter L.M., McMahon S.B., Bradbury E.J. Delayed treatment with chondroitinase ABC reverses chronic atrophy of rubrospinal neurons following spinal cord injury. Exp Neurol 2011, 228:149-156.
48. Cheever M.A., Schlom J., Weiner L.M., et al. Translational Research Working Group developmental pathway for immune response modifiers. Clin Cancer Res 2008, 14:5692-5699.
49. Chen A., Springer J.E. Neuroproteomic methods in spinal cord injury. Methods Mol Biol 2009, 566:57-67.
50. Choo A.M., Liu J., Liu Z., et al. Modeling spinal cord contusion, dislocation, and distraction: characterization of vertebral clamps, injury severities, and node of Ranvier deformations. J Neurosci Methods 2009, 181:6-17.
51. Cohen-Adad J., El Mendili M.M., Lehericy S., et al. Demyelination and degeneration in the injured human spinal cord detected with diffusion and magnetization transfer MRI. Neuroimage 2011, 55:1024-1033.
52. Cote M.P., Hanna A., Lemay M.A., et al. Peripheral nerve grafts after cervical spinal cord injury in adult cats. Exp Neurol 2010, 225:173-182.
53. Courtine G., Bunge M.B., Fawcett J.W., et al. Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans?. Nat Med 2007, 13:561-566.
54. Courtine G., Song B., Roy R.R., et al. Recovery of supraspinal control of stepping via indirect propriospinal relay connections after spinal cord injury. Nat Med 2008, 14:69-74.
55. Cummings B.J., Uchida N., Tamaki S.J., et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci U S A 2005, 102:14069-14074.
56. Darian-Smith C. Monkey models of recovery of voluntary hand movement after spinal cord and dorsal root injury. ILAR J 2007, 48:396-410.
57. Demopoulos H.B., Flamm E.S., Seligman M.L., et al. Further studies on free-radical pathology in the major central nervous system disorders: effect of very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury. Can J Physiol Pharmacol 1982, 60:1415-1424.
58. Dietz V. Body weight supported gait training: from laboratory to clinical setting. Brain Res Bull 2009, 78:I-VI.
59. Dietz V., Curt A. Neurological aspects of spinal-cord repair: promises and challenges. Lancet Neurol 2006, 5:688-694.
60. Dobkin B.H. Curiosity and cure: translational research strategies for neural repair-mediated rehabilitation. Dev Neurobiol 2007, 67:1133-1147.
61. Dobkin B., Barbeau H., Deforge D., et al. The evolution of walking-related outcomes over the first 12 weeks of rehabilitation for incomplete traumatic spinal cord injury: the multicenter randomized Spinal Cord Injury Locomotor Trial. Neurorehabil Neural Repair 2007, 21:25-35.
62. Donnelly D.J., Popovich P.G. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 2008, 209:378-388.
63. Dorfman G.S., Lawrence T.S., Matrisian L.M. The Translational Research Working Group developmental pathway for interventive devices. Clin Cancer Res 2008, 14:5700-5706.
64. Dorfman G.S., Sullivan D.C., Schnall M.D., et al. The Translational Research Working Group developmental pathway for image-based assessment modalities. Clin Cancer Res 2008, 14:5678-5684.
65. Duale H., Hou S., Derbenev A.V., et al. Spinal cord injury reduces the efficacy of pseudorabies virus labeling of sympathetic preganglionic neurons. J Neuropathol Exp Neurol 2009, 68:168-178.
66. Duale H., Lyttle T.S., Smith B.N., et al. Noxious colorectal distention in spinalized rats reduces pseudorabies virus labeling of sympathetic neurons. J Neurotrauma 2010, 27:1369-1378.
67. Edgerton V.R., Roy R.R. Robotic training and spinal cord plasticity. Brain Res Bull 2009, 78:4-12.
68. Edgerton V.R., Tillakaratne N.J., Bigbee A.J., et al. Plasticity of the spinal neural circuitry after injury. Annu Rev Neurosci 2004, 27:145-167.
69. Eftekharpour E., Karimi-Abdolrezaee S., Fehlings M.G. Current status of experimental cell replacement approaches to spinal cord injury. Neurosurg Focus 2008, 24:E19.
70. Eidelberg E., Staten E., Watkins C.J., et al. Treatment of experimental spinal cord injury in ferrets. Surg Neurol 1976, 6:243-246.
71. Eidelberg E., Staten E., Watkins J.C., et al. A model of spinal cord injury. Surg Neurol 1976, 6:35-38.
72. Fawcett J. Repair of spinal cord injuries: where are we, where are we going?. Spinal Cord 2002, 40:615-623.
73. Fawcett J.W., Curt A., Steeves J.D., et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 2007, 45:190-205.
74. Fehlings M.G. Editorial: recommendations regarding the use of methylprednisolone in acute spinal cord injury: making sense out of the controversy. Spine (Phila Pa 1976) 2001, 26:S56-S57.
75. Fehlings M.G., Perrin R.G. The role and timing of early decompression for cervical spinal cord injury: update with a review of recent clinical evidence. Injury 2005, 36:B13-B26.
76. Fiedler M., Horn C., Bandtlow C., et al. An engineered IN-1 F(ab) fragment with improved affinity for the Nogo-A axonal growth inhibitor permits immunochemical detection and shows enhanced neutralizing activity. Protein Eng 2002, 15:931-941.
77. Fournier A.E., Takizawa B.T., Strittmatter S.M. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci 2003, 23:1416-1423.
78. Frigon A., Rossignol S. Adaptive changes of the locomotor pattern and cutaneous reflexes during locomotion studied in the same cats before and after spinalization. J Physiol 2008, 586:2927-2945.
79. Gao J., Coggeshall R.E., Chung J.M., et al. Functional motoneurons develop from human neural stem cell transplants in adult rats. NeuroReport 2007, 18:565-569.
80. Garcia-Alias G., Lin R., Akrimi S.F., et al. Therapeutic time window for the application of chondroitinase ABC after spinal cord injury. Exp Neurol 2008, 210:331-338.
81. Garcia-Alias G., Barkhuysen S., Buckle M., et al. Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat Neurosci 2009, 12:1145-1151.
82. Geisler F.H., Dorsey F.C., Coleman W.P. GM1 gangliosides in the treatment of spinal cord injury: report of preliminary data analysis. Acta Neurobiol Exp (Wars) 1990, 50:515-521.
83. Geisler F.H., Dorsey F.C., Coleman W.P. Recovery of motor function after spinal-cord injury - a randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med 1991, 324:1829-1838.
84. Geisler F.H., Coleman W.P., Grieco G., et al. The Sygen multicenter acute spinal cord injury study. Spine (Phila Pa 1976) 2001, 26:S87-S98.
85. Gerasimenko Y., Gorodnichev R., Machueva E., et al. Novel and direct access to the human locomotor spinal circuitry. J Neurosci 2010, 30:3700-3708.
86. Glendinning D.S., Cooper B.Y., Vierck C.J., et al. Altered precision grasping in stumptail macaques after fasciculus cuneatus lesions. Somatosens Mot Res 1992, 9:61-73.
87. Goldberger M.E., Bregman B.S., Vierck C.J., et al. Criteria for assessing recovery of function after spinal cord injury: behavioral methods. Exp Neurol 1990, 107:113-117.
88. Gruner J.A. A monitored contusion model of spinal cord injury in the rat. J Neurotrauma 1992, 9:123-126. discussion 126-128.
89. Guest J.D., Hiester E.D., Bunge R.P. Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp Neurol 2005, 192:384-393.
90. Guest J., Benavides F., Padgett K., et al. Technical aspects of spinal cord injections for cell transplantation. Clinical and translational considerations. Brain Res Bull 2011, 84:267-279.
91. Guth L (2012). A reassessment of LPS/indomethacin/pregnenolone combination therapy after spinal cord injury in rats. Exp Neurol 233: 686.
92. Hall E.D., Braughler J.M. Acute effects of intravenous glucocorticoid pretreatment on the in vitro peroxidation of cat spinal cord tissue. Exp Neurol 1981, 73:321-324.
93. Hall E.D., Braughler J.M. Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rationale. Surg Neurol 1982, 18:320-327.
94. Hall E.D., Braughler J.M. Role of lipid peroxidation in post-traumatic spinal cord degeneration: a review. Cent Nerv Syst Trauma 1986, 3:281-294.
95. Hall E.D., Springer J.E. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 2004, 1:80-100.
96. Hall E.D., Traystman R.J. Role of animal studies in the design of clinical trials. Front Neurol Neurosci 2009, 25:10-33.
97. Hall E.D., Yonkers P.A., Andrus P.K., et al. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury. J Neurotrauma 1992, 9:S425-S442.
98. Harkema S.J. Plasticity of interneuronal networks of the functionally isolated human spinal cord. Brain Res Brain Res Rev 2008, 57:255-264.
99. Harris N.G., Mironova Y.A., Hovda D.A., et al. Chondroitinase ABC enhances pericontusion axonal sprouting but does not confer robust improvements in behavioral recovery. J Neurotrauma 2010, 27:1971-1982.
100. Hart C.B., Giszter S.F. A neural basis for motor primitives in the spinal cord. J Neurosci 2010, 30:1322-1336.
101. Hawk E.T., Matrisian L.M., Nelson W.G., et al. The Translational Research Working Group developmental pathways: introduction and overview. Clin Cancer Res 2008, 14:5664-5671.
102. Hawryluk G.W., Rowland J., Kwon B.K., et al. Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg Focus 2008, 25:E14.
103. Hendriks W.T., Ruitenberg M.J., Blits B., et al. Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. Prog Brain Res 2004, 146:451-476.
104. Hill C.E., Beattie M.S., Bresnahan J.C. Degeneration and sprouting of identified descending supraspinal axons after contusive spinal cord injury in the rat. Exp Neurol 2001, 171:153-169.
105. Hill R.L., Zhang Y.P., Burke D.A., et al. Anatomical and functional outcomes following a precise, graded, dorsal laceration spinal cord injury in C57BL/6 mice. J Neurotrauma 2009, 26:1-15.
106. Hofstetter C.P., Holmstrom N.A., Lilja J.A., et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci 2005, 8:346-353.
107. Houle J.D., Tessler A. Repair of chronic spinal cord injury. Exp Neurol 2003, 182:247-260.
108. Hsu C.Y. Criteria for valid preclinical trials. J Neurotrauma 1992, 9:177-179. discussion 179-181.
109. Hugenholtz H. Methylprednisolone for acute spinal cord injury: not a standard of care. CMAJ 2003, 168:1145-1146.
110. Hurlbert R.J. The role of steroids in acute spinal cord injury: an evidence-based analysis. Spine (Phila Pa 1976) 2001, 26:S39-S46.
111. Hyatt A.J., Wang D., Kwok J.C., et al. Controlled release of chondroitinase ABC from fibrin gel reduces the level of inhibitory glycosaminoglycan chains in lesioned spinal cord. J Control Release 2010, 147:24-29.
112. Iaci J.F., Vecchione A.M., Zimber M.P., et al. Chondroitin sulfate proteoglycans in spinal cord contusion injury and the effects of chondroitinase treatment. J Neurotrauma 2007, 24:1743-1759.
113. Inman D.M., Steward O. Physical size does not determine the unique histopathological response seen in the injured mouse spinal cord. J Neurotrauma 2003, 20:33-42.
114. Iseda T., Okuda T., Kane-Goldsmith N., et al. Single, high-dose intraspinal injection of chondroitinase reduces glycosaminoglycans in injured spinal cord and promotes corticospinal axonal regrowth after hemisection but not contusion. J Neurotrauma 2008, 25:334-349.
115. Ishibashi S., Sakaguchi M., Kuroiwa T., et al. Human neural stem/progenitor cells, expanded in long-term neurosphere culture, promote functional recovery after focal ischemia in Mongolian gerbils. J Neurosci Res 2004, 78:215-223.
116. Iwanami A., Yamane J., Katoh H., et al. Establishment of graded spinal cord injury model in a nonhuman primate: the common marmoset. J Neurosci Res 2005, 80:172-181.
117. Jakeman L.B., Guan Z., Wei P., et al. Traumatic spinal cord injury produced by controlled contusion in mouse. J Neurotrauma 2000, 17:299-319.
118. Jakeman L.B., Hoschouer E.L., Basso D.M. Injured mice at the gym: review, results and considerations for combining chondroitinase and locomotor exercise to enhance recovery after spinal cord injury. Brain Res Bull 2011, 84:317-326.
119. Jankowska E. Spinal interneuronal networks in the cat: elementary components. Brain Res Brain Res Rev 2008, 57:46-55.
120. Jefferson S.C., Tester N.J., Rose M., et al. Cough following low thoracic hemisection in the cat. Exp Neurol 2010, 222:165-170.
121. Jeffery N.D., Smith P.M., Lakatos A., et al. Clinical canine spinal cord injury provides an opportunity to examine the issues in translating laboratory techniques into practical therapy. Spinal Cord 2006, 44:584-593.
122. Jones L.L., Margolis R.U., Tuszynski M.H. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 2003, 182:399-411.
123. Kakulas B.A. The applied neuropathology of human spinal cord injury. Spinal Cord 1999, 37:79-88.
124. Kakulas B.A. Neuropathology: the foundation for new treatments in spinal cord injury. Spinal Cord 2004, 42:549-563.
125. Kalia M., DiPalma J.R. Ganglioside-induced acceleration of axonal transport following nerve crush injury in the rat. Neurosci Lett 1982, 34:1-5.
126. Kaneiwa T., Mizumoto S., Sugahara K., et al. Identification of human hyaluronidase-4 as a novel chondroitin sulfate hydrolase that preferentially cleaves the galactosaminidic linkage in the trisulfated tetrasaccharide sequence. Glycobiology 2010, 20:300-309.
127. Karimi-Abdolrezaee S., Eftekharpour E., Wang J., et al. Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J Neurosci 2010, 30:1657-1676.
128. Kastner A., Gauthier P. Are rodents an appropriate pre-clinical model for treating spinal cord injury? Examples from the respiratory system. Exp Neurol 2008, 213:249-256.
129. Kazanis I. CNS injury research; reviewing the last decade: methodological errors and a proposal for a new strategy. Brain Res Brain Res Rev 2005, 50:377-386.
130. Kigerl K.A., McGaughy V.M., Popovich P.G. Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J Comp Neurol 2006, 494:578-594.
131. Kigerl K.A., Gensel J.C., Ankeny D.P., et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009, 29:13435-13444.
132. Kim J.E., Li S., GrandPre T., et al. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 2003, 38:187-199.
133. Kleitman N. Keeping promises: translating basic research into new spinal cord injury therapies. J Spinal Cord Med 2004, 27:311-318.
134. Ko H.Y., Park J.H., Shin Y.B., et al. Gross quantitative measurements of spinal cord segments in human. Spinal Cord 2004, 42:35-40.
135. Kocsis J.D. Neuroprotection and immunomodulation by cell transplantation are becoming central themes in potential therapeutic approaches for cell-based therapies. Neurosci Lett 2009, 456:99.
136. Kocsis J.D., Akiyama Y., Radtke C. Neural precursors as a cell source to repair the demyelinated spinal cord. J Neurotrauma 2004, 21:441-449.
137. Konya D., Liao W.L., Choi H., et al. Functional recovery in T13-L1 hemisected rats resulting from peripheral nerve rerouting: role of central neuroplasticity. Regen Med 2008, 3:309-327.
138. Kuluz J., Samdani A., Benglis D., et al. Pediatric spinal cord injury in infant piglets: description of a new large animal model and review of the literature. J Spinal Cord Med 2010, 33:43-57.
139. Kwon B.K., Oxland T.R., Tetzlaff W. Animal models used in spinal cord regeneration research. Spine 2002, 27:1504-1510.
140. Kwon B.K., Oxland T.R., Tetzlaff W. Animal models used in spinal cord regeneration research. Spine (Phila Pa 1976) 2002, 27:1504-1510.
141. Kwon B.K., Fisher C.G., Dvorak M.F., et al. Strategies to promote neural repair and regeneration after spinal cord injury. Spine (Phila Pa 1976) 2005, 30:S3-S13.
142. Kwon B.K., Hillyer J., Tetzlaff W. Translational research in spinal cord injury: a survey of opinion from the SCI community. J Neurotrauma 2010, 27:21-33.
143. Kwon B.K., Stammers A.M., Belanger L.M., et al. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J Neurotrauma 2010, 27:669-682.
144. Kwon B.K., Okon E.B., Plunet W., et al. A systematic review of directly applied biologic therapies for acute spinal cord injury. J Neurotrauma 2011, 28:1589-1610.
145. Kwon B.K., Okon E.B., Tsai E., et al. A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury. J Neurotrauma 2011, 28:1525-1543.
146. Kwon B.K., Okon E., Hillyer J., et al. A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J Neurotrauma 2011, 28:1545-1588.
147. Lammertse D.P. Update on pharmaceutical trials in acute spinal cord injury. J Spinal Cord Med 2004, 27:319-325.
148. Lane M.A. Spinal respiratory motoneurons and interneurons. Respir Physiol Neurobiol 2011, 179:3-13.
149. Lane M.A., Fuller D.D., White T.E., et al. Respiratory neuroplasticity and cervical spinal cord injury: translational perspectives. Trends Neurosci 2008, 31:538-547.
150. Lane M.A., White T.E., Coutts M.A., et al. Cervical prephrenic interneurons in the normal and lesioned spinal cord of the adult rat. J Comp Neurol 2008, 511:692-709.
151. Lane M.A., Lee K.Z., Fuller D.D., et al. Spinal circuitry and respiratory recovery following spinal cord injury. Respir Physiol Neurobiol 2009, 169:123-132.
152. Laverty P.H., Leskovar A., Breur G.J., et al. A preliminary study of intravenous surfactants in paraplegic dogs: polymer therapy in canine clinical SCI. J Neurotrauma 2004, 21:1767-1777.
153. Lee H., McKeon R.J., Bellamkonda R.V. Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury. Proc Natl Acad Sci U S A 2010, 107:3340-3345.
154. Lee J.H., Tigchelaar S., Liu J., et al. Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury. Exp Neurol 2010, 225:219-230.
155. Lee J.K., Geoffroy C.G., Chan A.F., et al. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Neuron 2010, 66:663-670.
156. Lemons M.L., Howland D.R., Anderson D.K. Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation. Exp Neurol 1999, 160:51-65.
157. Leonard C.M., Glendinning D.S., Wilfong T., et al. Alterations of natural hand movements after interruption of fasciculus cuneatus in the macaque. Somatosens Mot Res 1992, 9:75-89.
158. Liebscher T., Schnell L., Schnell D., et al. Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol 2005, 58:706-719.
159. Lim J.H., Piedrahita J.A., Jackson L., et al. Development of a model of sacrocaudal spinal cord injury in cloned Yucatan minipigs for cellular transplantation research. Cell Reprogramming (formerly " Cloning and Stem Cells" ) 2010, 12:689-697.
160. Liu K., Lu Y., Lee J.K., et al. PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat Neurosci 2010, 13:1075-1081.
161. Longbrake E.E., Lai W., Ankeny D.P., et al. Characterization and modeling of monocyte-derived macrophages after spinal cord injury. J Neurochem 2007, 102:1083-1094.
162. Loy D.N., Magnuson D.S., Zhang Y.P., et al. Functional redundancy of ventral spinal locomotor pathways. J Neurosci 2002, 22:315-323.
163. Loy D.N., Talbott J.F., Onifer S.M., et al. Both dorsal and ventral spinal cord pathways contribute to overground locomotion in the adult rat. Exp Neurol 2002, 177:575-580.
164. Ma M., Basso D.M., Walters P., et al. Behavioral and histological outcomes following graded spinal cord contusion injury in the C57Bl/6 mouse. Exp Neurol 2001, 169:239-254.
165. Magnuson D.S., Trinder T.C., Zhang Y.P., et al. Comparing deficits following excitotoxic and contusion injuries in the thoracic and lumbar spinal cord of the adult rat. Exp Neurol 1999, 156:191-204.
166. Mann C.M., Lee J.H., Hillyer J., et al. Lack of robust neurologic benefits with simvastatin or atorvastatin treatment after acute thoracic spinal cord contusion injury. Exp Neurol 2010, 221:285-295.
167. Margulies S., Hicks R. Combination therapies for traumatic brain injury: prospective considerations. J Neurotrauma 2009, 26:925-939.
168. Massey J.M., Amps J., Viapiano M.S., et al. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp Neurol 2008, 209:426-445.
169. McKenna J.E., Whishaw I.Q. Complete compensation in skilled reaching success with associated impairments in limb synergies, after dorsal column lesion in the rat. J Neurosci 1999, 19:1885-1894.
170. McKenna J.E., Prusky G.T., Whishaw I.Q. Cervical motoneuron topography reflects the proximodistal organization of muscles and movements of the rat forelimb: a retrograde carbocyanine dye analysis. J Comp Neurol 2000, 419:286-296.
171. McKeon R.J., Schreiber R.C., Rudge J.S., et al. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J Neurosci 1991, 11:3398-3411.
172. McKerracher L., Higuchi H. Targeting Rho to stimulate repair after spinal cord injury. J Neurotrauma 2006, 23:309-317.
173. McTigue D.M., Tripathi R.B. The life, death, and replacement of oligodendrocytes in the adult CNS. J Neurochem 2008, 107:1-19.
174. Means E.D., Anderson D.K., Waters T.R., et al. Effect of methylprednisolone in compression trauma to the feline spinal cord. J Neurosurg 1981, 55:200-208.
175. Merkler D., Metz G.A., Raineteau O., et al. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J Neurosci 2001, 21:3665-3673.
176. Muir E.M., Fyfe I., Gardiner S., et al. Modification of N-glycosylation sites allows secretion of bacterial chondroitinase ABC from mammalian cells. J Biotechnol 2010, 145:103-110.
177. Nasonkin I., Mahairaki V., Xu L., et al. Long-term, stable differentiation of human embryonic stem cell-derived neural precursors grafted into the adult mammalian neostriatum. Stem Cells 2009, 27:2414-2426.
178. Navarro R., Juhas S., Keshavarzi S., et al. Chronic spinal compression model in minipigs: a systematic behavioral, qualitative, and quantitative neuropathological study. J Neurotrauma 2012, 29:499-513.
179. Noble L.J., Wrathall J.R. Spinal cord contusion in the rat: morphometric analyses of alterations in the spinal cord. Exp Neurol 1985, 88:135-149.
180. Noble L.J., Wrathall J.R. Correlative analyses of lesion development and functional status after graded spinal cord contusive injuries in the rat. Exp Neurol 1989, 103:34-40.
181. Norenberg M.D., Smith J., Marcillo A. The pathology of human spinal cord injury: defining the problems. J Neurotrauma 2004, 21:429-440.
182. O'Collins V.E., Macleod M.R., Donnan G.A., et al. 1,026 experimental treatments in acute stroke. Ann Neurol 2006, 59:467-477.
183. Pettersson L.G., Alstermark B., Blagovechtchenski E., et al. Skilled digit movements in feline and primate - recovery after selective spinal cord lesions. Acta Physiol (Oxf) 2007, 189:141-154.
184. Piao M.S., Lee J.K., Jang J.W., et al. A mouse model of photochemically induced spinal cord injury. J Korean Neurosurg Soc 2009, 46:479-483.
185. Pinzon A., Marcillo A., Pabon D., et al. A re-assessment of erythropoietin as a neuroprotective agent following rat spinal cord compression or contusion injury. Exp Neurol 2008, 213:129-136.
186. Pinzon A., Marcillo A., Quintana A., et al. A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model. Brain Res 2008, 1243:146-151.
187. Prado R., Dietrich W.D., Watson B.D., et al. Photochemically induced graded spinal cord infarction. Behavioral, electrophysiological, and morphological correlates. J Neurosurg 1987, 67:745-753.
188. Pritchard C.D., Slotkin J.R., Yu D., et al. Establishing a model spinal cord injury in the African green monkey for the preclinical evaluation of biodegradable polymer scaffolds seeded with human neural stem cells. J Neurosci Methods 2010, 188:258-269.
189. Qiu K., Lane M.A., Lee K.Z., et al. The phrenic motor nucleus in the adult mouse. Exp Neurol 2010, 226:254-258.
190. Raineteau O., Fouad K., Bareyre F.M., et al. Reorganization of descending motor tracts in the rat spinal cord. Eur J Neurosci 2002, 16:1761-1771.
191. Redmond D.E., Freeman T. The American Society for Neural Transplantation and Repair Considerations and guidelines for studies of human subjects. The practice committee of the society. Approved by council. Cell Transplant 2001, 10:661-664.
192. Reier P.J. Cellular transplantation strategies for spinal cord injury and translational neurobiology. NeuroRx 2004, 1:424-451.
193. Reier P.J., Anderson D.K., Young W., et al. Workshop on intraspinal transplantation and clinical application. J Neurotrauma 1994, 11:369-377.
194. Reier P.J., Golder F.J., Bolser D.C., et al. Gray matter repair in the cervical spinal cord. Prog Brain Res 2002, 137:49-70.
195. Rivlin A.S., Tator C.H. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol 1978, 10:38-43.
196. Rosenzweig E.S., McDonald J.W. Rodent models for treatment of spinal cord injury: research trends and progress toward useful repair. Curr Opin Neurol 2004, 17:121-131.
197. Rosenzweig E.S., Brock J.H., Culbertson M.D., et al. Extensive spinal decussation and bilateral termination of cervical corticospinal projections in rhesus monkeys. J Comp Neurol 2009, 513:151-163.
198. Rosenzweig E.S., Courtine G., Jindrich D.L., et al. Extensive spontaneous plasticity of corticospinal projections after primate spinal cord injury. Nat Neurosci 2010, 13:1505-1510.
199. Rossignol S., Schwab M., Schwartz M., et al. Spinal cord injury: time to move?. J Neurosci 2007, 27:11782-11792.
200. Rossignol S., Barriere G., Alluin O., et al. Re-expression of locomotor function after partial spinal cord injury. Physiology (Bethesda) 2009, 24:127-139.
201. Saino O., Taguchi A., Nakagomi T., et al. Immunodeficiency reduces neural stem/progenitor cell apoptosis and enhances neurogenesis in the cerebral cortex after stroke. J Neurosci Res 2010, 88:2385-2397.
202. Salazar D.L., Uchida K., Hamers F.P.T., et al. Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. PLoS One 2010, 5:e12272.
203. Sasaki M., Radtke C., Tan A.M., et al. BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J Neurosci 2009, 29:14932-14941.
204. Scheff S.W., Rabchevsky A.G., Fugaccia I., et al. Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J Neurotrauma 2003, 20:179-193.
205. Schilsky R.L., Gordon G., Gilmer T.M., et al. The Translational Research Working Group developmental pathway for anticancer agents (drugs or biologics). Clin Cancer Res 2008, 14:5685-5691.
206. Schnell L., Schwab M.E. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 1990, 343:269-272.
207. Schnell L., Schwab M.E. Sprouting and regeneration of lesioned corticospinal tract fibres in the adult rat spinal cord. Eur J Neurosci 1993, 5:1156-1171.
208. Schrimsher G.W., Reier P.J. Forelimb motor performance following dorsal column, dorsolateral funiculi, or ventrolateral funiculi lesions of the cervical spinal cord in the rat. Exp Neurol 1993, 120:264-276.
209. Sharp J., Keirstead H.S. Stem cell-based cell replacement strategies for the central nervous system. Neurosci Lett 2009, 456:107-111.
210. Shapiro S., Borgens R., Pascuzzi R., et al. Oscillating field stimulation for complete spinal cord injury in humans: a phase 1 trial. J Neurosurg Spine 2005, 2:3-10.
211. Shaw G., Yang C., Ellis R., et al. Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. Biochem Biophys Res Commun 2005, 336:1268-1277.
212. Simard J.M., Gerzanich V. When replication teaches more than the original experiment-the saga of the unknown. Exp Neurol 2012, 233:623-624.
213. Simonen M., Pedersen V., Weinmann O., et al. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 2003, 38:201-211.
214. Sipski M.L. From the bench to the body: key issues associated with research aimed at a cure for SCI. J Rehabil Res Dev 2003, 40:1-7.
215. Smith P.M., Jeffery N.D. Histological and ultrastructural analysis of white matter damage after naturally-occurring spinal cord injury. Brain Pathol 2006, 16:99-109.
216. Snyder E.Y., Teng Y.D. Stem cells and spinal cord repair. N Engl J Med 2012, 366:1940-1942.
217. Srivastava S., Gray J.W., Reid B.J., et al. Translational Research Working Group developmental pathway for biospecimen-based assessment modalities. Clin Cancer Res 2008, 14:5672-5677.
218. Sroga J.M., Jones T.B., Kigerl K.A., et al. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol 2003, 462:223-240.
219. Steencken A.C., Siebert J.R., Stelzner D.J. Lack of axonal sprouting of spared propriospinal fibers caudal to spinal contusion injury is attributed to chronic axonopathy. J Neurotrauma 2009, 26:2279-2297.
220. Steeves J., Fawcett J., Tuszynski M. Report of international clinical trials workshop on spinal cord injury February 20-21, 2004, Vancouver, Canada. Spinal Cord 2004, 42:591-597.
221. Steward O., Schauwecker P.E., Guth L., et al. Genetic approaches to neurotrauma research: opportunities and potential pitfalls of murine models. Exp Neurol 1999, 157:19-42.
222. Steward O., Sharp K., Yee K.M., et al. A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice. Exp Neurol 2008, 209:446-468.
223. Steward O., Sharp K., Yee K.M. A re-assessment of the effects of intracortical delivery of inosine on transmidline growth of corticospinal tract axons after unilateral lesions of the medullary pyramid. Exp Neurol 2012, 233:662-673.
224. Stokes B.T., Noyes D.H., Behrmann D.L. An electromechanical spinal injury technique with dynamic sensitivity. J Neurotrauma 1992, 9:187-195.
225. Stokols S., Tuszynski M.H. The fabrication and characterization of linearly oriented nerve guidance scaffolds for spinal cord injury. Biomaterials 2004, 25:5839-5846.
226. Straley K.S., Foo C.W., Heilshorn S.C. Biomaterial design strategies for the treatment of spinal cord injuries. J Neurotrauma 2010, 27:1-19.
227. Sung J.K., Miao L., Calvert J.W., et al. A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat. Brain Res 2003, 959:29-38.
228. Tang X., Davies J.E., Davies S.J. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res 2003, 71:427-444.
229. Tator C.H. Strategies for recovery and regeneration after brain and spinal cord injury. Inj Prev 2002, 8:IV33-36.
230. Tator C.H. Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations. Neurosurgery 2006, 59:957-982. discussion 982-987.
231. Teng Y.D., Lavik E.B., Qu X., et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A 2002, 99:3024-3029.
232. Teng Y.D., Liao W.L., Choi H., et al. Physical activity-mediated functional recovery after spinal cord injury: potential roles of neural stem cells. Regen Med 2006, 1:763-776.
233. Tester N.J., Howland D.R. Chondroitinase ABC improves basic and skilled locomotion in spinal cord injured cats. Exp Neurol 2008, 209:483-496.
234. Tester N.J., Plaas A.H., Howland D.R. Effect of body temperature on chondroitinase ABC's ability to cleave chondroitin sulfate glycosaminoglycans. J Neurosci Res 2007, 85:1110-1118.
235. Tetzlaff W., Okon E.B., Karimi-Abdolrezaee S., et al. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma 2011, 28:1611-1682.
236. Toffano G., Savoini G., Aldinio C., et al. Effects of gangliosides on the functional recovery of damaged brain. Adv Exp Med Biol 1984, 174:475-488.
237. Tolias C.M., Bullock M.R. Critical appraisal of neuroprotection trials in head injury: what have we learned?. NeuroRx 2004, 1:71-79.
238. Tom V.J., Houle J.D. Intraspinal microinjection of chondroitinase ABC following injury promotes axonal regeneration out of a peripheral nerve graft bridge. Exp Neurol 2008, 211:315-319.
239. Tom V.J., Kadakia R., Santi L., et al. Administration of chondroitinase ABC rostral or caudal to a spinal cord injury site promotes anatomical but not functional plasticity. J Neurotrauma 2009, 26:2323-2333.
240. Tsai E.C., Tator C.H. Neuroprotection and regeneration strategies for spinal cord repair. Curr Pharm Des 2005, 11:1211-1222.
241. Uccelli A., Pistoia V., Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression?. Trends Immunol 2007, 28:219-226.
242. van den Brand R., Heutschi J., Barraud Q., et al. Restoring voluntary control of locomotion after paralyzing spinal cord injury. Science 2012, 336:1182-1185.
243. van der Worp H.B., Howells D.W., Sena E.S., et al. Can animal models of disease reliably inform human studies?. PLoS Med 2010, 7:e1000245.
244. Velardo M.J., Burger C., Williams P.R., et al. Patterns of gene expression reveal a temporally orchestrated wound healing response in the injured spinal cord. J Neurosci 2004, 24:8562-8576.
245. Vierck C.J., Siddall P., Yezierski R.P. Pain following spinal cord injury: animal models and mechanistic studies. Pain 2000, 89:1-5.
246. Walmsley A.R., Mir A.K. Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury. Curr Pharm Des 2007, 13:2470-2484.
247. The Spinal Cord: A Christopher and Dana Reeve Foundation Text and Atlas 2009, Elsevier AP, Amsterdam. C. Watson, G. Paxinos, G. Kayalioglu (Eds.).
248. Weidner N., Tuszynski M.H. Spontaneous plasticity in the injured spinal cord-implications for repair strategies. Mol Psychiatry 2002, 7:9-11.
249. Wennersten A., Holmin S., Al Nimer F., et al. Sustained survival of xenografted human neural stem/progenitor cells in experimental brain trauma despite discontinuation of immunosuppression. Exp Neurol 2006, 199:339-347.
250. Wewetzer K., Radtke C., Kocsis J., et al. Species-specific control of cellular proliferation and the impact of large animal models for the use of olfactory ensheathing cells and Schwann cells in spinal cord repair. Exp Neurol 2011, 229:80-87.
251. White T.E., Lane M.A., Sandhu M.S., et al. Neuronal progenitor transplantation and respiratory outcomes following upper cervical spinal cord injury in adult rats. Exp Neurol 2010, 225:231-236.
252. Wolpaw J.R., Tennissen A.M. Activity-dependent spinal cord plasticity in health and disease. Annu Rev Neurosci 2001, 24:807-843.
253. Yan J., Xu L., Welsh A.M., et al. Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord. PLoS Med 2007, 4:e39.
254. Yang J.W., Jeong S.M., Seo K.M., et al. Effects of corticosteroid and electroacupuncture on experimental spinal cord injury in dogs. J Vet Sci 2003, 4:97-101.
255. Yang H., Lu P., McKay H.M., et al. Endogenous neurogenesis replaces oligodendrocytes and astrocytes after primate spinal cord injury. J Neurosci 2006, 26:2157-2166.
256. Young W. Spinal cord injury pathophysiology and therapy. Neurotrauma 1996, McGraw-Hill, New York. R.K. Narayan, J.J.E. Wilberger, J.T. Povlishock (Eds.).
257. Young W., DeCrescito V., Flamm E.S., et al. Pharmacological therapy of acute spinal cord injury: studies of high dose methylprednisolone and naloxone. Clin Neurosurg 1988, 34:675-697.
258. Yu D., Neeley W.L., Pritchard C.D., et al. Blockade of peroxynitrite-induced neural stem cell death in the acutely injured spinal cord by drug-releasing polymer. Stem Cells 2009, 27:1212-1222.
259. Zheng B., Ho C., Li S., et al. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron 2003, 38:213-224.
260. Zorner B., Schwab M.E. Anti-Nogo on the go: from animal models to a clinical trial. Ann N Y Acad Sci 2010, 1198:E22-E34.